Morning. IMO after some sifting through some of last year's...

Morning.

IMO after some sifting through some of last year's announcements, I've come to the conclusion that this article was published due to efforts from the Bonvie group - one of our distribution Partners over in Greece. Specifically I'm referring to this announcement:

"Neurotech secures Greek medical devices specialist Bonvie Group as distribution partner. Perth-Australia, Athens- Greece & Malta– Neurotech International Limited (ASX: NTI) (“Neurotech” or the “Company”), developer of quality medical solutions in the neuroscience space, has secured the Bonvie Group (“Bonvie”) as its marketing and distribution partner for Mente Autism in Greece and Cyprus"

Interestingly the timing of the fully published results and the modifications made to the mentee autism device fits perfectly for our first shipment over to Greece:

"Neurotech expects to ship the first batch of devices in May"

As I pointed out in my previous post - sales of the mentee autism device are likely to increase from this quarter onwards due to the new modifications and due to the fact that it has been accepted by medical professionals in the current publication.

Excellent info and video on their website explaining the mentee device

http://www.bonviegroup.com/en/products/mente-autism-2

Clear the skies Zeus!



Cheers

Red bar